Passage Bio, Inc.
PASG
$7.48
-$0.065-0.86%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 25.75% | 24.84% | 36.54% | 38.78% | 31.61% |
| Total Depreciation and Amortization | -45.13% | -30.23% | -17.20% | -17.90% | -12.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 69.26% | 53.18% | 20.45% | -45.10% | -15.42% |
| Change in Net Operating Assets | 94.42% | 70.07% | -175.33% | -131.81% | -219.56% |
| Cash from Operations | 49.02% | 42.64% | 38.73% | 28.68% | 18.69% |
| Capital Expenditure | -100.00% | 71.67% | 76.71% | 94.56% | 97.99% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 20.15% | -0.89% | -15.91% | -10.90% | 101.91% |
| Cash from Investing | 22.21% | 0.08% | -15.77% | -9.97% | 108.16% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.31% | -98.51% | 6,473.33% | 5,776.16% | 3,757.83% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.31% | -98.51% | 6,473.33% | 1,878.16% | 1,078.28% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 695.11% | 681.65% | 223.05% | 95.56% | 90.93% |